Deregulation of autophagy and vesicle trafficking in Parkinson's disease
- PMID: 29627340
- PMCID: PMC6173655
- DOI: 10.1016/j.neulet.2018.04.013
Deregulation of autophagy and vesicle trafficking in Parkinson's disease
Abstract
Parkinson's disease (PD) is a common neurodegenerative disease characterized pathologically by the selective loss of dopaminergic neurons in the substantia nigra and the intracellular accumulation of α-synuclein in the Lewy bodies. While the pathogenic mechanisms of PD are poorly understood, many lines of evidence point to a role of altered autophagy and membrane trafficking in the development of the disease. Emerging studies show that connections between the deregulation of autophagy and synaptic vesicle (SV) trafficking may contribute to PD. Here we review the evidence that many PD related-genes have roles in both autophagy and SV trafficking and examine how deregulation of these pathways contributes to PD pathogenesis. This review also discusses recent studies aimed at uncovering the role of PD-linked genes in autophagy-lysosome function.
Keywords: Autophagy; LRRK2; Parkinson’s disease; Synaptic trafficking.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
None.
Figures


Similar articles
-
Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.J Neurosci. 2017 Nov 22;37(47):11366-11376. doi: 10.1523/JNEUROSCI.0964-17.2017. Epub 2017 Oct 20. J Neurosci. 2017. PMID: 29054882 Free PMC article.
-
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.Int J Mol Sci. 2019 Oct 25;20(21):5312. doi: 10.3390/ijms20215312. Int J Mol Sci. 2019. PMID: 31731450 Free PMC article. Review.
-
Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease.Neurobiol Dis. 2019 Feb;122:64-71. doi: 10.1016/j.nbd.2018.04.020. Epub 2018 May 1. Neurobiol Dis. 2019. PMID: 29723605 Free PMC article. Review.
-
LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.Proc Natl Acad Sci U S A. 2018 May 22;115(21):5576-5581. doi: 10.1073/pnas.1717590115. Epub 2018 May 7. Proc Natl Acad Sci U S A. 2018. PMID: 29735704 Free PMC article.
-
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.Trends Neurosci. 2019 Feb;42(2):140-149. doi: 10.1016/j.tins.2018.11.001. Epub 2018 Nov 30. Trends Neurosci. 2019. PMID: 30509690 Free PMC article. Review.
Cited by
-
Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease.Front Neurol. 2021 Aug 6;12:694329. doi: 10.3389/fneur.2021.694329. eCollection 2021. Front Neurol. 2021. PMID: 34421799 Free PMC article. Review.
-
The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes.Int J Mol Sci. 2019 Aug 10;20(16):3903. doi: 10.3390/ijms20163903. Int J Mol Sci. 2019. PMID: 31405128 Free PMC article.
-
Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson's Disease.Cells. 2020 Apr 30;9(5):1115. doi: 10.3390/cells9051115. Cells. 2020. PMID: 32365906 Free PMC article. Review.
-
Autophagy in Parkinson's Disease.J Mol Biol. 2020 Apr 3;432(8):2651-2672. doi: 10.1016/j.jmb.2020.01.037. Epub 2020 Feb 13. J Mol Biol. 2020. PMID: 32061929 Free PMC article. Review.
-
Identification of Key Genes and Immunological Features Associated with Copper Metabolism in Parkinson's Disease by Bioinformatics Analysis.Mol Neurobiol. 2024 Feb;61(2):799-811. doi: 10.1007/s12035-023-03565-8. Epub 2023 Sep 2. Mol Neurobiol. 2024. PMID: 37659036
References
-
- Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Past, present, and future of Parkinson’s disease: A special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord. 2017;32:1264–1310. - PMC - PubMed
-
- Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR International Parkinson’s Disease Genomics C, T 23andMe Research. A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet. 2017;49:1511–1516. - PMC - PubMed
-
- Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez HH, Foote KD, Rodriguez RL, Peckham E, De Vrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A. Genome-wide genotyping in Parkinson’s disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2006;5:911–916. - PubMed
-
- Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet. 2009;41:1308–1312. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical